A large French prospective cohort of HIV-infected patients: The Nadis Cohort

HIV Medicine

Volumn 10, Issue 8, 2009, Pages 504-511

  Pugliese, P ^a   Cuzin, L ^b   Cabie A ^c,d,p   Poizot Martin, I ^e   Allavena, C ^f   Duvivier, C ^g,h,i   El Guedj, M ^j   De La Tribonniere X ^k   Valantin, M A ^{g,h,i,l,m,n,o}   Dellamonica, P ^a   Poizot Martin, Isabelle ^p   Enel, Patricia ^p   Drogoul Vey, Marie Pierre ^p   Obry Roguet, Véronique ^p   Gastaut, Jean Albert ^p   Marchou, Bruno ^p   Massip, Patrice ^p   Bonnet, Eric ^p   Obadia, Martine ^p   Alvarez, Muriel ^p   Cuzin, Lise ^p   Porte, Lydie ^p   Barone, Martine ^p   Pugliese, Pascal ^p   Pradier, Christian ^p   Durant, Jacques ^p   Ferrando, Sarah ^p   Vassallo, Matteo ^p   Perbost, Isabelle ^p   Roger, Pierre Marie ^p   Bentz, Laurence ^p   Prouvost Keller, Bernard ^p   De Salvador, Francine ^p   Mondain, Véronique ^p   Dellamonica, Pierre ^p   Billaud, Eric ^p   Allavena, Clotilde ^p   Jovelin, Thomas ^p   Guerbois, Christine ^p   Raffi, François ^p   de la Tribonnière, Xavier ^p   Choisy, Philippe ^p   Yazdanpanah, Yazdan ^p   Duvivier, Claudine ^p   Agher, Rachid ^p   Katlama, Christine ^p   Abel, Sylvie ^p   Pierre François, Sandrine ^p   El Guedj, Myriam ^p   more..

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CHU PURPAN   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^d Epidémiologie Clinique Antilles   (France)

^e HÔPITAL SAINTE MARGUERITE   (France)

^f HÔTEL DIEU   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ INSERM   (France)

^j CENTRE HOSPITALIER DE CAYENNE   (French Guiana)

^k CENTRE HOSPITALIER DE TOURCOING   (France)

^l HÔPITAL NECKER ENFANTS MALADES   (France)

^m UNIVERSITÉ PARIS DESCARTES   (France)

ⁿ INSTITUT PASTEUR   (France)

^o Centre d'Infectiologie Necker Pasteur   (France)

^p NONE

more..

Author keywords

Antiretroviral treatment; Atazanavir ritonavir; HIV infection; Protease inhibitor

Indexed keywords

ANTIRETROVIRUS AGENT; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; COHORT ANALYSIS; DATA COLLECTION METHOD; DELAYED DIAGNOSIS; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RESIDENTIAL AREA; SEX DIFFERENCE; VIRUS DIAGNOSIS; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 68449083219     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00719.x     Document Type: Article

References (28)

1. Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: Comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS 1999; 13: 2075-2082.
2. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-1892.
3. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med 2008; 168: 136-140.
4. Gandhi M, Ameli N, Bacchetti P et al. Eligibility criteria for HIV clinical trials and generalizability of results: The gap between published reports and study protocols. AIDS 2005; 19: 1885-1896.
5. The UK Collaborative HIV Cohort Steering Committee. The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study. HIV Med 2004; 5: 115-124.
6. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips AN, Rezza G. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study. BMJ 1994; 309: 1537-1542.
7. Grabar S, Pradier C, Le Corfec E et al. Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS 2000; 14: 141-149.
8. Moorman AC, Holmberg SD, Marlowe SI et al. Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: The HIV Outpatient Study (HOPS). Ann Epidemiol 1999; 9: 349-357.
9. Pugliese P, Cuzin L, Enel P et al. NADIS 2000, développement d'un dossier médical informatisépour les patients infectés par VIH, VHB et VHC. Presse Med 2003; 32: 299-303.
10. Hogan WR, Wagner MM. Accuracy of data in computer-based patient records. J Am Med Inform Assoc 1997; 4: 342-355.
11. Brown PJ, Warmington V. Data quality probes-exploiting and improving the quality of electronic patient record data and patient care. Int J Med Inf 2002; 68: 91-98.
12. Yeni P. Prise en charge médicale des personnes infectées par le VIH. Recommandations du groupe d'experts. Paris: Flammarion Médecine-Sciences, 2008.
13. Agher R, Duvivier C, Katlama C et al. The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals. Med Mal Infect 2005; 35: 407-410.
14. Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years. Clin Infect Dis 2007; 45: 654-657.
15. Cuzin L, Pugliese P, Bugnon F et al. Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: Efficacy and durability in a prospective cohort of French HIV-infected patients. HIV Med 2005; 6: 388-395.
16. de la Tribonniere X, Pugliese P, Cabie A et al. Demographic, clinical, immunovirological and therapeutic features of 8714 HIV-infected French patients included in the Nadis Hospital Cohort in 2006. Med Mal Infect 2008; 38: 299-308.
17. Delpierre C, Cuzin L, Lauwers-Cances V, Datta G, Berkman L, Lang T. Unemployment as a risk factor of AIDS and death for HIV-infected patients in the era of HAART. Sex Transm Infect 2008; 84: 183-186.
18. Delpierre C, Cuzin L, Lauwers-Cances V, Marchou B, Lang T. High-Risk groups for late diagnosis of HIV infection: A need for rethinking testing policy in the general population. AIDS Patient Care STDS 2006; 20: 838-847.
19. Delpierre C, Dray-Spira R, Cuzin L et al. Correlates of late HIV diagnosis: Implications for testing policy. Int J STD AIDS 2007; 18: 312-317.
20. Poizot-Martin I, Pugliese P, Enel P et al. Medical care for HIV infection in France in 2005, the NADIS cohort study on 7416 patients. Med Mal Infect 2006; 36: 454-459.
21. Nacher M, El Guedj M, Vaz T et al. Risk factors for follow-up interruption of HIV patients in French Guiana. Am J Trop Med Hyg 2006; 74: 915-917.
22. Granlien MF, Hertzum M, Gudmundsen J. The gap between actual and mandated use of an electronic medication record three years after deployment. Stud Health Technol Inform 2008; 136: 419-424.
23. Dorr D, Bonner LM, Cohen AN et al. Informatics systems to promote improved care for chronic illness: A literature review. J Am Med Inform Assoc 2007; 14: 156-163.
24. DesRoches CM, Campbell EG, Rao SR et al. Electronic health records in ambulatory care - a national survey of physicians. N Engl J Med 2008; 359: 50-60.
25. Lebouche B, Yazdanpanah Y, Gerard Y et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med 2006; 7: 140-145.
26. Mocroft A, Kirk O, Aldins P et al. Loss to follow-up in an international, multicentre observational study. HIV Med 2008; 9: 261-269.
27. Lanoy E, Mary-Krause M, Tattevin P et al. Predictors identified for losses to follow-up among HIV-seropositive patients. J Clin Epidemiol 2006; 59: 829-835.
28. Cabie A, Abel S, Pugliese P, Cuzin L, Pierre-François S, Billaud E. Interêt de Nadis dans l'organisation des dispositifs hospitaliers d'évaluation des pratiques professionnelles (EPP). Med Mal Infect 2007; 37: S120.